We are live on ! Find out more
Capital Research Global Investors

Capital Research Global Investors Portfolio holdings

AUM $717B
1-Year Est. Return 35.42%
 

Capital Research Global Investors (CRGI), a division of Capital Group established in 1931 and headquartered in Los Angeles, California, is a powerhouse in active investment management, overseeing hundreds of billions in assets with a focus on global equity portfolios. Known for its long-term, research-intensive approach, CRGI employs a unique multiple-portfolio-manager system to diversify risk and enhance returns, serving institutional clients, financial advisors, and individual investors through vehicles like the American Funds mutual fund family. The firm’s investment philosophy emphasizes fundamental analysis and a deep understanding of companies worldwide, aiming to identify growth opportunities over extended horizons. As part of Capital Group’s broader mission, CRGI has built a reputation for delivering consistent, value-driven results in the global investment landscape.

This Fund
S&P 500
This Quarter Est. Return
-6.67%
1 Year Est. Return
+35.42%
3 Year Est. Return
+133.7%
5 Year Est. Return
+183.13%
10 Year Est. Return
+734.77%
AUM
$280B
AUM Growth
-$24.7B
Cap. Flow
+$1.03B
Cap. Flow %
0.37%
Top 10 Hldgs %
24.98%
Holding
460
New
27
Increased
141
Reduced
116
Closed
18

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$3.33B
2
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
+$1.39B
3
AMZN icon
Amazon
AMZN
+$1.32B
4
NFLX icon
Netflix
NFLX
+$1.14B
5
AAPL icon
Apple
AAPL
+$938M

Sector Composition

Rank Sector Weight
1 Healthcare 20.04%
2 Communication Services 12.94%
3 Industrials 11.83%
4 Technology 11.7%
5 Consumer Staples 8.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIDU icon
26
Baidu
BIDU
$35.6B
$2.41B 0.86%
17,527,574
+5,071,684
+41% +$836M
GE icon
27
GE Aerospace
GE
$379B
$2.3B 0.82%
19,047,424
+40,481
+0.2% +$4.96M
CSX icon
28
CSX Corp
CSX
$92.8B
$2.27B 0.81%
253,319,106
+3,067,200
+1% +$30.1M
MON
29
DELISTED
Monsanto Co
MON
$2.25B 0.8%
26,321,350
+4,681,843
+22% +$463M
KO icon
30
Coca-Cola
KO
$373B
$2.23B 0.8%
55,586,974
+14,116,000
+34% +$565M
TMO icon
31
Thermo Fisher Scientific
TMO
$223B
$2.21B 0.79%
18,078,000
+401,300
+2% +$52.3M
LMT icon
32
Lockheed Martin
LMT
$140B
$2.02B 0.72%
9,734,286
-99,600
-1% -$20.3M
NSC icon
33
Norfolk Southern
NSC
$75.3B
$2.02B 0.72%
26,396,466
-524,120
-2% -$42.6M
MDT icon
34
Medtronic
MDT
$116B
$2B 0.72%
29,907,000
-2,253,000
-7% -$166M
BMRN icon
35
BioMarin Pharmaceuticals
BMRN
$13.6B
$1.99B 0.71%
18,940,220
-697,601
-4% -$93.2M
STJ
36
DELISTED
St Jude Medical
STJ
$1.98B 0.71%
31,435,896
-3,274,104
-9% -$234M
ILMN icon
37
Illumina
ILMN
$29.1B
$1.84B 0.66%
10,736,007
+1,908,996
+22% +$386M
DLR icon
38
Digital Realty Trust
DLR
$72.9B
$1.81B 0.65%
97,651,429
-169,194
-0.2% -$11M
PGR icon
39
Progressive
PGR
$121B
$1.75B 0.63%
57,205,155
COP icon
40
ConocoPhillips
COP
$153B
$1.72B 0.62%
35,952,725
+19,657,125
+121% +$1B
NLSN
41
DELISTED
Nielsen Holdings plc
NLSN
$1.69B 0.6%
+37,939,968
New +$1.75B
CNQ icon
42
Canadian Natural Resources
CNQ
$98.1B
$1.67B 0.6%
176,872,981
-27,631,430
-14% -$304M
EXC icon
43
Exelon
EXC
$46.6B
$1.64B 0.59%
77,398,931
-14,563,693
-16% -$327M
JCI icon
44
Johnson Controls International
JCI
$92.6B
$1.63B 0.58%
37,653,065
-2,309,785
-6% -$106M
STT icon
45
State Street
STT
$52.2B
$1.54B 0.55%
22,858,416
+5,600,387
+32% +$417M
CMI icon
46
Cummins
CMI
$87.8B
$1.51B 0.54%
13,890,199
+167,000
+1% +$20.6M
BRK.B icon
47
Berkshire Hathaway Class B
BRK.B
$1.09T
$1.49B 0.53%
11,420,033
+8,078,753
+242% +$1.11B
MSFT icon
48
Microsoft
MSFT
$3.66T
$1.45B 0.52%
32,827,855
+4,304,780
+15% +$193M
SU icon
49
Suncor Energy
SU
$74.7B
$1.43B 0.51%
53,546,795
+9,500,249
+22% +$255M
VIAB
50
DELISTED
Viacom Inc. Class B
VIAB
$1.41B 0.5%
+32,690,380
New +$1.62B

Similar funds

Capital Research Global Investors's Q3 2015 Portfolio in Review

As of Q3 2015, Capital Research Global Investors held 460 positions worth $280B, down 8.1% from $304B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Capital Research Global Investors's Q3 2015 filing shows 27 new, 141 increased, 116 reduced and 18 closed positions. Its largest new stake was Nielsen Holdings plc: 37,939,968 shares worth $1.69B. The largest sale was Gilead Sciences, an estimated $3.33B.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 22% a quarter earlier, followed by Communication Services and Industrials.

  • Capital Research Global Investors's largest Q3 2015 buy was Nielsen Holdings plc: 37,939,968 shares worth $1.69B.
  • Capital Research Global Investors added most to Twenty-First Century Fox, Inc. Class A in Q3 2015, an estimated $1.21B increase.
  • Capital Research Global Investors's biggest Q3 2015 reduction was Gilead Sciences, cutting an estimated $3.33B.
  • Capital Research Global Investors fully exited KRAFT FOODS GROUP INC COM STK (VA) in Q3 2015, selling an estimated $1.39B.
  • Capital Research Global Investors's ten largest holdings make up 25% of its $280B portfolio in Q3 2015.
  • Capital Research Global Investors opened 27 new positions and closed 18 in Q3 2015.
  • Capital Research Global Investors's portfolio value fell 8.1% quarter-over-quarter to $280B.

Based on Capital Research Global Investors's 13F filing for Q3 2015, filed 16 Nov 2015.